BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31689277)

  • 1. Granulomatous Myositis Showing Fluctuating "Leopard-Man" Sign: A Case Report on FDG PET/CT Imaging.
    Koyama M; Terauchi T; Koizumi M; Sugiura Y
    Clin Nucl Med; 2019 Dec; 44(12):961-963. PubMed ID: 31689277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy].
    Dufour JF; Billotey C; Streichenberger N; Bouhour F; Broussolle C; Sève P
    Rev Med Interne; 2007 Aug; 28(8):568-70. PubMed ID: 17445952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F18-FDG PET/CT in a patient with Antisynthetase Syndrome.
    Nazerani-Zemann T; Stanzel S; Gstettner C; Aigner RM; Pernthaler B
    Nuklearmedizin; 2023 Apr; 62(2):73-74. PubMed ID: 36599440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoid-like granulomatous myositis-associated hypercalcemia. An infrequent case to consider.
    Uslar T; Olmos R; Godoy-Santin J; Mellado P; Gonzalez G
    Medicina (B Aires); 2021; 81(3):462-466. PubMed ID: 34137710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal and Bone Metastases as the Initial Presentation of Endometrial Carcinoma Diagnosed by 18F-FDG PET/CT.
    Su M; Sun J; Fan Q; Tian R
    Clin Nucl Med; 2020 Sep; 45(9):711-713. PubMed ID: 32520505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT and MRI in Necrotizing Autoimmune Myopathy: "The Scarface Sign".
    Pelissou C; Lerolle N; Labeyrie C; Durand E; Besson FL
    Clin Nucl Med; 2018 Feb; 43(2):147-149. PubMed ID: 29261630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia revealing diffuse granulomatous myositis.
    Caré W; Blanc E; Cournac JM; Doutrelon C; Aletti M; Lecoules S
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1413-1414. PubMed ID: 28396910
    [No Abstract]   [Full Text] [Related]  

  • 8. Focal Inflammatory Myositis on 18F-FDG PET/CT.
    Bennett O; Ravi Kumar AS; Agnew J
    Clin Nucl Med; 2016 Jun; 41(6):469-71. PubMed ID: 27055132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and Myositis Revisited: Emerging Role of Fluorine-18 Fluorodeoxyglucose PET in Muscle Imaging.
    Debs P; Al-Zaghal A; Solnes LB; Alavi A
    PET Clin; 2023 Jan; 18(1):31-38. PubMed ID: 36442964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Myositis of the Leg Presenting as Fever of Unknown Origin Detected by FDG PET/CT.
    Dong A; Bai Y; Wang Y
    Clin Nucl Med; 2019 Mar; 44(3):251-254. PubMed ID: 30562199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary Splenic Metastasis From Endometrial Carcinoma Revealed on FDG PET/CT.
    Xiao L; Li Y; Li L
    Clin Nucl Med; 2022 Dec; 47(12):e744-e745. PubMed ID: 35605058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
    Kara T; Kara PO; Gedik GK; Sari O
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
    Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
    Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
    Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
    Yin H; Hu Y; Xiu Y; Luo R; Shi H
    Clin Nucl Med; 2019 Jul; 44(7):e425-e427. PubMed ID: 30985410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation Recall Myositis Detected With 18F-FDG PET/CT After a Treatment of Cervical Cancer.
    Lemay J; Bouchard M; Rousseau É
    Clin Nucl Med; 2020 Jul; 45(7):e336-e338. PubMed ID: 32332309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
    Salvatore B; D'Amico D; Fonti R
    Clin Nucl Med; 2018 May; 43(5):363-364. PubMed ID: 29485436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pre-treatment 18F-FDG PET/CT parameters in endometrial cancer.
    Pacella S; Grappeja L
    Ann Nucl Med; 2024 Jan; 38(1):85. PubMed ID: 38012336
    [No Abstract]   [Full Text] [Related]  

  • 20. FDG-PET Assessment of Other Gynecologic Cancers.
    Faria S; Devine C; Viswanathan C; Javadi S; Korivi BR; Bhosale PR
    PET Clin; 2018 Apr; 13(2):203-223. PubMed ID: 29482750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.